Axcan expected to match LHC bid for Scandipharm

Article Abstract:

Montreal, Canada-based Axcan Pharma Inc is expected to up its $85-million offer to purchase Birmingham, AL-based Scandipharm Inc to equal Wilmington, DE-based investment firm LHC Corp's competing offer of $8 per share, or $98 million. Axcan aims to provide Scandipharm shareholders an alternative to LHC's offer by amending its current offer of $7 per share. Shares of Scandipharm, a leading supplier of drugs and nutritional supplements for treating cystic fibrosis, is owned by employees, local investors, management, the founding Wingett family and LHC.

Asset sales & divestitures, Acquisitions & mergers, Open-End Investment Funds, Pharmaceutical Preparations, Alabama, Delaware, Investment Companies, Axcan Pharma Inc., Scandipharm Inc.

---

Dimethaid stock rises 8% on expectations for arthritis lotion

Article Abstract:

Dimethaid Research Inc's announcement that it will introduce results of phase III clinical test on its topical arthritis lotion Pennsaid at at medical convention in Vienna, Austria, sent the Markham, Ontario-based drug company's stock price up 8%. Results indicated that the group receiving Pennsaid treatment showed statistically significant pain relief. Pennsaid is currently in wait to be approved by regulatory agencies in the US, Canada and the UK.

Product development, Analgesic Ointments, Jellies, Salves, Dimethaid Research Inc., Topical analgesics

---

Similar abstracts:

• Abstracts: Glaxo seeks flu drug approval. QLT shares rise on drug price tag
• Abstracts: Second Northwest union seeks 30-day strike deadline. Shippers in position for strike
• Abstracts: Nortel gets it--wrong. TD's Baillie highest-paid bank boss at $8.5-million. Governments buckle to privatization trend
• Abstracts: Philip to take results of copper probe to police. Philip pushed to hand ownership to lenders
• Abstracts: Speedy Int'l selling European operations. RioCan to fight realfund vote dare

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.